Physician profile
Nathan Sinz
NPI 1154988632
$4,465.38
in general payments reported to CMS, 2019-2025
11 companies · $1,203 in 2025
The $1,203 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.77 · 2020: $27.27 · 2021: $317 · 2022: $95.07 · 2023: $143 · 2024: $2,650 · 2025: $1,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,587 · Travel and Lodging: $1,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,586.62 |
| Travel and Lodging | $1,408.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $1,408.86 | 2024 | |
| Depuy Synthes Sales INC. | $1,167.04 | 2024-2025 | Velys, Trialtis, Spine & Trauma 3d Navigation |
| Stryker Corporation | $630.82 | 2021-2024 | Hoffmann, T2 Alpha, Ortholoc 3di |
| Smith+Nephew, INC. | $555.93 | 2024 | Trigen, Maverick, Taylor Spatial Frame |
| Globus Medical, INC. | $368.36 | 2023-2025 | Sable, Excelsius Gps, Distal Femur Plate System |
| Alphatec Spine, INC | $98.45 | 2025 | |
| Medical Device Business Services, INC. | $89.79 | 2024 | Skyline |
| Integra Lifesciences Corporation | $52.61 | 2020-2021 | |
| Solventum Corporation | $35.68 | 2024 | V.A.C. Veraflo Cleanse Choice |
| Tei Biosciences INC | $30.77 | 2019 | |
| Orthofix Medical, INC. | $27.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Sinz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.